SMCTM-Powered Next Generation Immunodiagnostics is Revolutionizing Medicine
Singulex’s SMC technology has enabled the creation of Next Generation Immunodiagnostics (NGI). SMC diagnostics are 100 times more sensitive than other current testing platforms, enabling unprecedented security to medical decisions. Simply stated, NGI measures biomarkers at levels as minute as 10 femtograms/ml, revealing what couldn’t be achieved before: distinguishing people who have disease from those who do not, before clinical symptoms are apparent. Such information provides clinicians with unparalleled, trusted insights into their patients’ health status and disease risk, enabling earlier disease diagnosis, monitoring for worsening or improvements in health, as well as more quickly and definitively ruling out of disease. Such definite answers from simple SMC-powered NGI blood tests are a valuable tool for physicians for enhanced clinical judgments regarding the appropriate use of costly and inconvenient procedures.
Learn how Singulex technology works:
For Researchers
For Clinicians
For Patients
Read about the Technology Innovation Award which Singulex received